Jan 29, 2026
What evidence exists tying the Guam lytico‑bodig toxin research to specific therapeutic mechanisms or targets?
The body of research points away from a single “toxin→symptom” pathway and toward converging neuropathological signatures—abnormal, prion‑like protein aggregates and tau‑dominated neurofibrillary tang...